Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease (ESRD)
A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects With Genotype 1, 4, 5 and 6 Chronic HCV Infection Who Are on Dialysis for End Stage Renal Disease
Sponsor: Gilead Sciences
Listed as NCT03036839, this PHASE2 trial focuses on Hepatitis C Virus Infection and remains completed. Sponsored by Gilead Sciences, it has been updated 22 times since 2017, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
22 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 17 earlier versions
-
Jan 2020 — Apr 2020 [monthly]
Completed PHASE2
-
Jul 2019 — Jan 2020 [monthly]
Completed PHASE2
-
Mar 2019 — Jul 2019 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE2
-
Nov 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Mar 2018 — May 2018 [monthly]
Recruiting PHASE2
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE2
-
Jan 2018 — Feb 2018 [monthly]
Recruiting PHASE2
-
Dec 2017 — Jan 2018 [monthly]
Recruiting PHASE2
-
Nov 2017 — Dec 2017 [monthly]
Recruiting PHASE2
-
Sep 2017 — Nov 2017 [monthly]
Recruiting PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gilead Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Antella, Italy , Boston, United States , Brussels, Belgium , Changhua, Taiwan , Dallas, United States , Detroit, United States , Frankfurt, Germany , Hamburg, Germany , Kaohsiung City, Taiwan , Leipzig, Germany and 8 more locations